Award-winning broadcast journalist Christina Gonzalez has been a general assignment reporter for FOX 11 since 1990. She has anchored and tried her hand at management, but always returns to her ...
While this is solid financial advice, some finance experts, like entrepreneur Mark Cuban, think a large portion of your portfolio should be in cash. When it comes to investing, few can match the ...
As Ioana Crisan, Chief Financial Officer of AstraZeneca Switzerland, emphasises, the entire sales force is also travelling electrically: “Knowing that the switch to electric cars poses challenges, we ...
Mark and Rhea Wahlberg are parents of four children. Mark Wahlberg is one proud dad! The Wahlbergs are known to proudly share on social media the milestones and achievements of their kids, Brendan ...
AstraZeneca said its breast cancer drug candidate showed positive results in a late stage trial, with improved progression-free survival in patients. The British pharma giant said Wednesday that ...
Mark Bradford was born in Los Angeles, California, in 1961. He received a BFA (1995) and MFA (1997) from the California Institute of the Arts in Valencia. Bradford transforms materials scavenged from ...
Is Mark Tilbury a millionaire? Yes. He has an estimated net worth of $8 million as of 2025. He makes around $60,000 per week through various sources of income. Some of his earnings are as follows: The ...
I commend Assemblymember Mark Gonzalez for his leadership on this important educational measure." "Dual Language Immersion is an important part of ensuring all Californians have access to ...
Mark A. Brave, 39, who had been indicted on 13 charges, acknowledged his guilt on one count of theft by deception, one count of falsifying physical evidence, and two counts of perjury, according ...
FibroGen sells its China unit to AstraZeneca for about $160M, strengthening its cash position and extending its financial runway into 2027. AstraZeneca gains full rights to roxadustat in China ...
AstraZeneca is paying $160 million for FibroGen’s China business, giving the U.K.-based Big Pharma the regional rights to oral anemia drug roxadustat. The two companies' relationship around ...